Literature DB >> 24723329

Sample collection in clinical proteomics--proteolytic activity profile of serum and plasma.

Kalyani Jambunathan1, Amit K Galande.   

Abstract

PURPOSE: Proteolytic enzymes are promising diagnostic targets since they play key roles in diverse physiological processes and have been implicated in numerous human diseases. Human blood is a relatively noninvasive source for disease-specific protease biomarker detection and subsequent translation into diagnostic tests. However, the choice of serum or plasma, and more specifically, which anticoagulant to choose in plasma preparation, is important to address in the sample preparation phase of biomarker discovery. EXPERIMENTAL
DESIGN: We have previously utilized a combinatorial library of internally quenched fluorogenic probes to successfully map the global proteolytic profiles of various biological fluids. In this study, we utilized the platform to ascertain the impact of three commonly used anticoagulants (EDTA, heparin, and citrate) on the proteolytic activity profile of plasma and serum collected from a healthy Caucasian male.
RESULTS: Serum and plasma citrate were observed to be most proteolytically active, followed by plasma heparin and then plasma EDTA. Detailed analysis of the amino acid distribution of motifs cleaved and not cleaved by the samples offered significant insights in to active proteolytic components within them. CONCLUSION AND CLINICAL RELEVANCE: Broad quantitative comparison of proteolytic profiles of these samples revealed several novel insights related to the differential substrate recognition of proteases present in these biological fluids.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Anticoagulants; Combinatorial library; Fluorogenic probes; Plasma; Proteases; Serum

Mesh:

Substances:

Year:  2014        PMID: 24723329     DOI: 10.1002/prca.201300037

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  5 in total

1.  The heparin-binding proteome in normal pancreas and murine experimental acute pancreatitis.

Authors:  Quentin M Nunes; Dunhao Su; Philip J Brownridge; Deborah M Simpson; Changye Sun; Yong Li; Thao P Bui; Xiaoying Zhang; Wei Huang; Daniel J Rigden; Robert J Beynon; Robert Sutton; David G Fernig
Journal:  PLoS One       Date:  2019-06-18       Impact factor: 3.240

Review 2.  Determination of amino acids in human biological fluids by high-performance liquid chromatography: critical review.

Authors:  Grażyna Gałęzowska; Joanna Ratajczyk; Lidia Wolska
Journal:  Amino Acids       Date:  2021-05-24       Impact factor: 3.520

3.  A Pathway Proteomic Profile of Ischemic Stroke Survivors Reveals Innate Immune Dysfunction in Association with Mild Symptoms of Depression - A Pilot Study.

Authors:  Vinh A Nguyen; Leeanne M Carey; Loretta Giummarra; Pierre Faou; Ira Cooke; David W Howells; Tamara Tse; S Lance Macaulay; Henry Ma; Stephen M Davis; Geoffrey A Donnan; Sheila G Crewther
Journal:  Front Neurol       Date:  2016-06-14       Impact factor: 4.003

Review 4.  Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease.

Authors:  Michelle J Pena; Harald Mischak; Hiddo J L Heerspink
Journal:  Diabetologia       Date:  2016-06-25       Impact factor: 10.122

5.  Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum.

Authors:  Roland Böttger; Ralf Hoffmann; Daniel Knappe
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.